Valuing a company with no revenue sounds like guesswork, and partly it is. But it's structured guesswork. Investors use a handful of methods to anchor their thinking, and if you understand them you can propose a number that holds up in negotiation instead of one you picked because it sounded good.
The honest truth about early valuations
At pre-seed and early seed, valuation is set more by the market than by any formula. What matters most is:
- what similar companies in your sector and region raised at recently,
- how many investors want in, and
- how much money you need, since investors generally want a certain ownership percentage.
The methods below help you and your investors reason about those factors. None of them produces a "true" value. Use two or three together and look for where they agree.
Method 1: Comparable rounds
This is the method that drives most real-world negotiations. Find 10 to 20 companies that raised at your stage in the last year or two, in your sector and geography, and look at their valuations or caps.
Sources include funding announcements (some disclose valuation), founder conversations, investor blog posts, accelerator data, SAFE cap norms in your network, and paid databases. Founders are often surprisingly open about their caps in private.
Then adjust. Is your team stronger or weaker than the comparables? Your traction ahead or behind? Your market bigger or smaller? Place yourself within the range.
Method 2: The scorecard method
The scorecard method, popularised by angel investor Bill Payne, starts with the average pre-money valuation for pre-revenue companies in your region and adjusts it based on how you compare on several factors.
A typical weighting:
| Factor | Weight |
|---|---|
| Strength of the team | 30% |
| Size of the opportunity | 25% |
| Product or technology | 15% |
| Competitive environment | 10% |
| Marketing, sales and partnerships | 10% |
| Need for additional investment | 5% |
| Other factors | 5% |
You rate your company against the average on each factor, say 125% for a stronger team, 80% for a tougher competitive environment, multiply by the weights and add up.
Illustrative example. Average regional pre-money for pre-revenue startups: $4M.
Team 130% × 0.30 = 0.39. Opportunity 120% × 0.25 = 0.30. Product 100% × 0.15 = 0.15. Competition 80% × 0.10 = 0.08. Sales 90% × 0.10 = 0.09. Further funding 100% × 0.05 = 0.05. Other 100% × 0.05 = 0.05.
Total factor = 1.11. Valuation ≈ $4M × 1.11 = $4.44M pre-money.
The weakness is the starting average. Get that wrong and everything else is off. Use local data and recent rounds.
Method 3: The Berkus method
Created by angel investor Dave Berkus, this method assigns value to five risk-reducing elements, each up to a fixed maximum. The original version capped each element at $500,000, giving a maximum pre-revenue valuation of $2.5 million. Many investors now scale the amounts up for current market conditions.
- Sound idea (basic value, product risk)
- Prototype (reduces technology risk)
- Quality management team (reduces execution risk)
- Strategic relationships (reduces market risk)
- Product rollout or sales (reduces production risk)
It's simple and useful for thinking through which risks you've retired. It's less useful for setting a precise number, especially in sectors where valuations have moved a long way from the original assumptions.
Method 4: Risk factor summation
This method also starts with an average regional pre-money valuation and then adjusts it up or down for 12 risk categories: management, stage of the business, legislation and political risk, manufacturing, sales and marketing, funding, competition, technology, litigation, international, reputation, and potential lucrative exit.
Each risk is scored from −2 (very high risk) to +2 (very low risk), and each point adds or subtracts a fixed amount, commonly $250,000. It forces you to think about risks investors will raise, which makes it a good preparation tool even if nobody in the room uses it formally.
Method 5: The VC method
The VC method works backwards from an exit. It asks: if this company succeeds, what might it be worth, and what valuation today gives the investor their target return?
The steps:
- Estimate the company's revenue in, say, seven years if things go well.
- Apply an exit multiple based on comparable acquisitions or public companies.
- Divide by the target return multiple the investor needs.
- Adjust for dilution from future rounds.
Illustrative example. Projected year-7 revenue $40M. Exit multiple 5x revenue gives a $200M exit value. An early-stage investor targeting a 20x return on a successful deal: $200M ÷ 20 = $10M post-money today, before dilution. Expecting about 50% dilution from later rounds, the investor might be comfortable at roughly $5M post-money.
The VC method explains why investors care so much about market size. If the realistic exit is small, the valuation today has to be small too, or the investor simply can't make the maths work.
Method 6: Cost to duplicate
This asks how much it would cost to build the company from scratch: development time, equipment, patents, data. It's most relevant for deep tech or hardware where significant R&D has already been done.
The weakness is obvious: cost doesn't equal value. A team could spend $2 million building something nobody wants. Investors rarely use this as their main method, but it can support a floor in asset-heavy businesses.
Putting the methods together
Here's a practical approach:
- Start with comparable rounds to set a realistic range.
- Use the scorecard or risk factor method to place yourself within that range and explain why.
- Run the VC method to check that the number makes sense for an investor given your market size.
- Work out how much you need to raise and check the resulting dilution. See how much equity to give seed investors.
If the methods point to very different numbers, that's useful information. It usually means your market-size story or your stage is unclear.
How to talk about valuation with investors
- Let the market speak. Saying "comparable companies at our stage have raised on caps of $X to $Y, and here's why we think we're toward the upper end" is far more convincing than quoting a formula.
- Lead with the raise, not the valuation. "We're raising $750,000 on a SAFE" invites conversation. A high number in the first email can end it.
- Be ready to move. If several investors push back on the same number, it's probably too high.
- Remember competition sets price. The single best way to improve your valuation is to have more than one investor who wants to lead.
What moves a pre-revenue valuation up or down
Whatever method an investor uses, the same handful of factors tend to push the number around. Knowing them helps you focus your pitch on the things that actually change price.
| Pushes valuation up | Pushes valuation down |
|---|---|
| Founders with a prior exit or deep domain expertise | First-time team with no direct experience in the market |
| Several investors competing to lead | Only one interested investor, or none yet |
| Strong signs of pull: waitlist engagement, LOIs, paid pilots | No evidence of demand beyond interviews |
| Large, clearly growing market | Niche market with limited exit options |
| Hard-to-copy technology or data advantage | Product easily replicated by incumbents |
| Sector currently attracting investor attention | Sector out of favour with investors |
| Capital-efficient path to next milestones | Large amounts needed before any proof point |
You can influence most of these. The fastest ways to improve your position before a raise are usually to turn interest into paid pilots, line up more than one potential lead, and sharpen the story about why your team is uniquely placed.
Common valuation mistakes
- Anchoring on outliers. A headline-grabbing round at a huge valuation isn't a comparable. Look at the middle of the distribution, not the top.
- Confusing caps and valuations. A SAFE cap isn't the same as a priced valuation. Caps often run a little higher because investors also benefit from the conversion mechanics.
- Ignoring the next round. If you raise at a valuation that requires spectacular growth to justify, you risk a flat or down round later.
- Over-engineering. A 40-tab model for a pre-revenue company looks more like procrastination than rigour. Keep it simple and defensible.
Frequently asked questions
What is the most common way to value a pre-revenue startup?
In practice, comparable rounds: looking at what similar companies at the same stage, in the same sector and region, recently raised at.
What is the Berkus method?
A pre-revenue valuation method that assigns value to five risk-reducing elements: the idea, a prototype, the team, strategic relationships and early sales.
What is the VC method of valuation?
It estimates a future exit value and works backwards using the investor's target return and expected dilution to arrive at an acceptable valuation today.
Can a pre-revenue startup have a high valuation?
Yes, particularly with an exceptional team, a very large market or strong investor competition, but high early valuations raise the bar for the next round.
Which valuation method do angel investors prefer?
Angel groups often use the scorecard or risk factor summation methods because they give a structured way to compare many early companies. Individual angels tend to rely more on comparable rounds and gut feel about the team.
Should I put a valuation in my pitch deck?
Usually not. Mention how much you are raising and what it funds. Discuss valuation or cap once an investor is interested, so the number doesn't end the conversation before it starts.